Trauzold A - Search Results

1

Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.

Kürbitz C, Heise D, Redmer T, Goumas F, Arlt A, Lemke J, Rimbach G, Kalthoff H, Trauzold A. Kürbitz C, et al. Among authors: trauzold a. Cancer Sci. 2011 Apr;102(4):728-34. doi: 10.1111/j.1349-7006.2011.01870.x. Epub 2011 Feb 24. Cancer Sci. 2011. PMID: 21241417 Free article.

2

The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.

Schäfer H, Diebel J, Arlt A, Trauzold A, Schmidt WE. Schäfer H, et al. Among authors: trauzold a. FEBS Lett. 1998 Oct 2;436(2):139-43. doi: 10.1016/s0014-5793(98)01109-0. FEBS Lett. 1998. PMID: 9781666 Free article.

3

p22/PRG1: a novel early response gene in pancreatic cancer cells regulated by p53 and NF kappa B.

Schmidt WE, Arlt A, Trauzold A, Schäfer H. Schmidt WE, et al. Among authors: trauzold a. Ann N Y Acad Sci. 1999 Jun 30;880:147-56. doi: 10.1111/j.1749-6632.1999.tb09517.x. Ann N Y Acad Sci. 1999. PMID: 10415858 No abstract available.

4

The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.

Schäfer H, Arlt A, Trauzold A, Hünermann-Jansen A, Schmidt WE. Schäfer H, et al. Among authors: trauzold a. Biochem Biophys Res Commun. 1999 Aug 19;262(1):139-45. doi: 10.1006/bbrc.1999.1131. Biochem Biophys Res Commun. 1999. PMID: 10448082

5

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.

Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H. Hinz S, et al. Among authors: trauzold a. Oncogene. 2000 Nov 16;19(48):5477-86. doi: 10.1038/sj.onc.1203936. Oncogene. 2000. PMID: 11114725

6

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.

Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H. Trauzold A, et al. Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559. Oncogene. 2001. PMID: 11464292

7

FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis.

Ungefroren H, Kruse ML, Trauzold A, Roeschmann S, Roeder C, Arlt A, Henne-Bruns D, Kalthoff H. Ungefroren H, et al. Among authors: trauzold a. J Cell Sci. 2001 Aug;114(Pt 15):2735-46. doi: 10.1242/jcs.114.15.2735. J Cell Sci. 2001. PMID: 11683408

8

Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells.

Trauzold A, Schmiedel S, Röder C, Tams C, Christgen M, Oestern S, Arlt A, Westphal S, Kapischke M, Ungefroren H, Kalthoff H. Trauzold A, et al. Br J Cancer. 2003 Nov 3;89(9):1714-21. doi: 10.1038/sj.bjc.6601330. Br J Cancer. 2003. PMID: 14583775 Free PMC article.

9

PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells.

Trauzold A, Schmiedel S, Sipos B, Wermann H, Westphal S, Röder C, Klapper W, Arlt A, Lehnert L, Ungefroren H, Johannes FJ, Kalthoff H. Trauzold A, et al. Oncogene. 2003 Dec 4;22(55):8939-47. doi: 10.1038/sj.onc.1207001. Oncogene. 2003. PMID: 14654790

10

Concerted deregulations of multiple apoptosis-controlling genes in pancreatic carcinoma cells.

Trauzold A, Schmiedel S, Oestern S, Christgen M, Westphal S, Roederm C, Kalthoff H. Trauzold A, et al. Ann N Y Acad Sci. 2003 Dec;1010:510-3. doi: 10.1196/annals.1299.094. Ann N Y Acad Sci. 2003. PMID: 15033781 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters